[Brain atrophy and cognitive impairment in patients with chronic kidney disease].

Kazuhiko Tsuruya

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Many recent reports have shown that prevalence of brain atrophy (BA) and cognitive impairment (CI) increases in patients with chronic kidney disease (CKD), and is also associated with the severity of kidney dysfunction. Various risk factors such as dialysis-related factors, oxidative stress, anemia, brain ischemia, and uremic toxins are considered to involve in these conditions. We recently reported that CI in CKD mice were ameliorated by the treatment with tempol, an antioxidant drug, thorough inhibition of oxidative stress in the brain. Moreover, it has been reported that renal transplantation are effective in the improvement of CI; however, increase in hemodialysis by frequent hemodialysis had failed to improve CI in CKD patients. Further evidences are required to elucidate the pathogenesis of BA and CI in CKD.

Original languageEnglish
Pages (from-to)708-714
Number of pages7
JournalNihon rinsho. Japanese journal of clinical medicine
Volume72
Issue number4
Publication statusPublished - Apr 2014

Fingerprint

Chronic Renal Insufficiency
Atrophy
Brain
Renal Dialysis
Oxidative Stress
Brain Ischemia
Kidney Transplantation
Anemia
Dialysis
Antioxidants
Cognitive Dysfunction
Kidney
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[Brain atrophy and cognitive impairment in patients with chronic kidney disease]. / Tsuruya, Kazuhiko.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 72, No. 4, 04.2014, p. 708-714.

Research output: Contribution to journalArticle

@article{2fe6398c129e418fac7e34607c780634,
title = "[Brain atrophy and cognitive impairment in patients with chronic kidney disease].",
abstract = "Many recent reports have shown that prevalence of brain atrophy (BA) and cognitive impairment (CI) increases in patients with chronic kidney disease (CKD), and is also associated with the severity of kidney dysfunction. Various risk factors such as dialysis-related factors, oxidative stress, anemia, brain ischemia, and uremic toxins are considered to involve in these conditions. We recently reported that CI in CKD mice were ameliorated by the treatment with tempol, an antioxidant drug, thorough inhibition of oxidative stress in the brain. Moreover, it has been reported that renal transplantation are effective in the improvement of CI; however, increase in hemodialysis by frequent hemodialysis had failed to improve CI in CKD patients. Further evidences are required to elucidate the pathogenesis of BA and CI in CKD.",
author = "Kazuhiko Tsuruya",
year = "2014",
month = "4",
language = "English",
volume = "72",
pages = "708--714",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "4",

}

TY - JOUR

T1 - [Brain atrophy and cognitive impairment in patients with chronic kidney disease].

AU - Tsuruya, Kazuhiko

PY - 2014/4

Y1 - 2014/4

N2 - Many recent reports have shown that prevalence of brain atrophy (BA) and cognitive impairment (CI) increases in patients with chronic kidney disease (CKD), and is also associated with the severity of kidney dysfunction. Various risk factors such as dialysis-related factors, oxidative stress, anemia, brain ischemia, and uremic toxins are considered to involve in these conditions. We recently reported that CI in CKD mice were ameliorated by the treatment with tempol, an antioxidant drug, thorough inhibition of oxidative stress in the brain. Moreover, it has been reported that renal transplantation are effective in the improvement of CI; however, increase in hemodialysis by frequent hemodialysis had failed to improve CI in CKD patients. Further evidences are required to elucidate the pathogenesis of BA and CI in CKD.

AB - Many recent reports have shown that prevalence of brain atrophy (BA) and cognitive impairment (CI) increases in patients with chronic kidney disease (CKD), and is also associated with the severity of kidney dysfunction. Various risk factors such as dialysis-related factors, oxidative stress, anemia, brain ischemia, and uremic toxins are considered to involve in these conditions. We recently reported that CI in CKD mice were ameliorated by the treatment with tempol, an antioxidant drug, thorough inhibition of oxidative stress in the brain. Moreover, it has been reported that renal transplantation are effective in the improvement of CI; however, increase in hemodialysis by frequent hemodialysis had failed to improve CI in CKD patients. Further evidences are required to elucidate the pathogenesis of BA and CI in CKD.

UR - http://www.scopus.com/inward/record.url?scp=84901421424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901421424&partnerID=8YFLogxK

M3 - Article

C2 - 24796102

AN - SCOPUS:84901421424

VL - 72

SP - 708

EP - 714

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 4

ER -